United States · FDA National Drug Code directory
Cefuroxime Axetil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-058_d7e9c50b-74c7-4c0b-9c73-8802fa288cd8
- Product NDC
- 57237-058
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cefuroxime Axetil
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060329
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFUROXIME AXETIL — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE (57237-058-20) · 57237-058-20
- 60 TABLET, FILM COATED in 1 BOTTLE (57237-058-60) · 57237-058-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →